Table 2. Treatments by Sex.
| Variables | Thrombolytic therapy |
Thrombolytic therapy and/or thrombectomy |
Medical therapy alone |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Women | Men | P | All | Women | Men | P | All | Women | Men | P | All | |
| Anticoagulants (%) | 34 (6.5) | 35 (6.5) | 0.544 | 69 (6.5) | 33 (20.0) | 28 (13.3) | 0.053 | 61 (16.2) | 949 (14.5) | 782 (12.0) | < 0.001 | 1731 (13.3) |
| Antiaggregants (%) | 246 (47.2) | 297 (55.2) | 0.006 | 543 (51.3) | 61 (37.0) | 104 (49.3) | 0.011 | 165 (43.9) | 3,216 (49.2) | 3,722 (57.1) | < 0.001 | 6,938 (53.2) |
| Statins (%) | 221 (42.4) | 282 (52.4) | 0.001 | 503 (47.5) | 75 (45.5) | 123 (58.3) | 0.009 | 198 (52.7) | 2,777 (42.5) | 3,255 (49.9) | < 0.001 | 6,032 (46.2) |
| Antidiabetics (%) | 98 (18.8) | 141 (26.2) | 0.002 | 239 (22.6) | 33 (20.0) | 52 (24.6) | 0.173 | 85 (22.6) | 1,698 (26.0) | 2,138 (32.8) | < 0.001 | 3,836 (29.4) |
| Diuretics (%) | 203 (39.0) | 144 (26.8) | < 0.001 | 347 (32.8) | 58 (35.2) | 50 (23.7) | 0.01 | 108 (28.7) | 2,953 (45.2) | 2,038 (31.3) | < 0.001 | 4,991 (38.2) |
| ACEIs (%) | 176 (33.8) | 172 (32.0) | 0.287 | 348 (32.9) | 57 (34.5) | 74 (35.1) | 0.502 | 131 (34.8) | 2,425 (37.1) | 2,652 (40.7) | < 0.001 | 5,077 (38.9) |
| AII-RA | 178 (34.2) | 153 (28.4) | 0.026 | 331 (31.3) | 47 (28.5) | 61 (28.9) | 0.511 | 108 (28.7) | 1,975 (30.2) | 1,706 (26.2) | < 0.001 | 3,681 (28.2) |
| Beta-blocker | 176 (33.8) | 176 (32.7) | 0.381 | 352 (33.2) | 49 (29.7) | 75 (35.3) | 0.139 | 124 (33.0) | 1,798 (27.5) | 1,616 (24.8) | < 0.001 | 3,414 (26.2) |
ACEI: angiotensin converting enzyme inhibitor; AII-RA: angiotensin II receptor antagonists.